Orchard Therapeutics PLC
Change company Symbol lookup
Select an option...
ORTX Orchard Therapeutics PLC
TOO-E Teekay Offshore Partners LP
TBT ProShares UltraShort 20+ Year Treasury
ASDTX AllianzGI Short Duration High Income Fund
ETR Entergy Corp
ET Energy Transfer LP
ESS Essex Property Trust Inc
ES Eversource Energy
EPR EPR Properties

Health Care : Biotechnology |
Based in United KingdomCompany profile

Orchard Therapeutics plc, formerly Orchard Rx Ltd, is a commercial-stage, fully-integrated biopharmaceutical company. It is engaged in manufacturing and commercialization of gene and cell therapies, position to provide transformative therapies to patients suffering from a range of rare diseases. The Company is focused on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders and hemoglobinopathies. Its portfolio includes Strimvelis, its commercial-stage gammaretroviral-based product for the treatment of ADA-SCID five lentiviral product candidates in clinical-stage development and several other product candidates in preclinical development. It is developing OTL-101 as an autologous ex vivo lentiviral gene therapy to sustainably treat patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID) through a single administration.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

Thinking about buying stock in Aurora Cannabis Inc, Canopy Growth Corp, Chesapeake Energy, Pier 1 Imports or Constellation Brands?

9:31 am ET January 9, 2019 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for ACB, CGC, CHK, PIR, and STZ.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

-- ACB: https://www.investorsobserver.com/pr-stocks-lp/?stocksymbol=ACB&prnumber=010920190

-- CGC: https://www.investorsobserver.com/pr-stocks-lp/?stocksymbol=CGC&prnumber=010920190

-- CHK: https://www.investorsobserver.com/pr-stocks-lp/?stocksymbol=chk&prnumber=010920190

-- PIR: https://www.investorsobserver.com/pr-stocks-lp/?stocksymbol=PIR&prnumber=010920190

-- STZ: https://www.investorsobserver.com/pr-stocks-lp/?stocksymbol=STZ&prnumber=010920190

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.


View original content:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-aurora-cannabis-inc-canopy-growth-corp-chesapeake-energy-pier-1-imports-or-constellation-brands-300775564.html

SOURCE InvestorsObserver


Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.